Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Catalyst Pharmaceuticals ...

    NASDAQ: CPRX · Real-Time Price · USD
    21.78
    -0.11 (-0.50%)
    At close: Jun 27, 2025, 3:59 PM
    22.15
    1.70%
    After-hours: Jun 27, 2025, 05:55 PM EDT

    Catalyst Pharmaceuticals Statistics

    Share Statistics

    Catalyst Pharmaceuticals has 121.97M shares outstanding. The number of shares has increased by 2.82% in one year.

    Shares Outstanding

    n/a
    		 121.97M

    Shares Change (YoY)

    n/a
    		 2.82%

    Shares Change (QoQ)

    n/a
    		 1.83%

    Owned by Institutions (%)

    n/a
    		 82.08%

    Shares Floating

    n/a
    		 111.11M

    Failed to Deliver (FTD) Shares

    n/a
    		 28

    FTD / Avg. Volume

    n/a
    		 n/a

    Short Selling Information

    The latest short interest is 7.35M, so 6.02% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 7.35M

    Short % of Shares Out

    n/a
    		 6.02%

    Short % of Float

    n/a
    		 7.7%

    Short Ratio (days to cover)

    n/a
    		 7.77

    Valuation Ratios

    The PE ratio is 15.08 and the forward PE ratio is 11.89. Catalyst Pharmaceuticals's PEG ratio is 0.14.

    PE Ratio

    n/a
    		 15.08

    Forward PE

    n/a
    		 11.89

    PS Ratio

    n/a
    		 5.03

    Forward PS

    n/a
    		 3.1

    PB Ratio

    n/a
    		 3.4

    P/FCF Ratio

    n/a
    		 10.33

    PEG Ratio

    n/a
    		 0.14
    Financial Ratio History

    Enterprise Valuation

    Catalyst Pharmaceuticals has an Enterprise Value (EV) of 1.96B.

    EV / Sales

    n/a
    		 3.98

    EV / EBITDA

    n/a
    		 8.41

    EV / EBIT

    n/a
    		 8.16

    EV / FCF

    n/a
    		 8.18

    Financial Position

    The company has a current ratio of 5.17, with a Debt / Equity ratio of 0.

    Current Ratio

    n/a
    		 5.17

    Quick Ratio

    n/a
    		 5.01

    Debt / Equity

    n/a
    		 0

    Debt / EBITDA

    n/a
    		 0.01

    Debt / FCF

    n/a
    		 0.01

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is 22.52% and Return on Invested Capital is 20.22%.

    Return on Equity

    n/a
    		 22.52%

    Return on Assets

    n/a
    		 19.25%

    Return on Invested Capital

    n/a
    		 20.22%

    Revenue Per Employee

    n/a
    		 $2,716,762.43

    Profits Per Employee

    n/a
    		 $905,464.09

    Employee Count

    n/a
    		 181

    Asset Turnover

    n/a
    		 0.58

    Inventory Turnover

    n/a
    		 3.52

    Taxes

    Income Tax

    n/a
    		 52.37M

    Effective Tax Rate

    n/a
    		 24.22%

    Stock Price Statistics

    The stock price has increased by 45.48% in the last 52 weeks. The beta is 0.72, so Catalyst Pharmaceuticals's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.72

    52-Week Price Change

    n/a
    		 45.48%

    50-Day Moving Average

    n/a
    		 23.85

    200-Day Moving Average

    n/a
    		 22.34

    Relative Strength Index (RSI)

    n/a
    		 33.25

    Average Volume (20 Days)

    n/a
    		 1,465,679

    Income Statement

    In the last 12 months, Catalyst Pharmaceuticals had revenue of 491.73M and earned 163.89M in profits. Earnings per share was 1.38.

    Revenue

    n/a
    		 491.73M

    Gross Profit

    n/a
    		 422.89M

    Operating Income

    n/a
    		 195.12M

    Net Income

    n/a
    		 163.89M

    EBITDA

    n/a
    		 232.9M

    EBIT

    n/a
    		 195.12M

    Earnings Per Share (EPS)

    n/a
    		 1.38
    Full Income Statement

    Balance Sheet

    The company has 517.55M in cash and 3.19M in debt, giving a net cash position of 514.37M.

    Cash & Cash Equivalents

    n/a
    		 517.55M

    Total Debt

    n/a
    		 3.19M

    Net Cash

    n/a
    		 514.37M

    Retained Earnings

    n/a
    		 285.16M

    Total Assets

    n/a
    		 908.87M

    Working Capital

    n/a
    		 574.07M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was 239.81M and capital expenditures -556K, giving a free cash flow of 239.25M.

    Operating Cash Flow

    n/a
    		 239.81M

    Capital Expenditures

    n/a
    		 -556K

    Free Cash Flow

    n/a
    		 239.25M

    FCF Per Share

    n/a
    		 2.02
    Full Cash Flow Statement

    Margins

    Gross margin is 86%, with operating and profit margins of 39.68% and 33.33%.

    Gross Margin

    n/a
    		 86%

    Operating Margin

    n/a
    		 39.68%

    Pretax Margin

    n/a
    		 43.98%

    Profit Margin

    n/a
    		 33.33%

    EBITDA Margin

    n/a
    		 47.36%

    EBIT Margin

    n/a
    		 39.68%

    FCF Margin

    n/a
    		 48.65%

    Dividends & Yields

    CPRX does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 6.63%

    FCF Yield

    n/a
    		 9.68%
    Dividend Details

    Analyst Forecast

    The average price target for CPRX is $32.5, which is 48.5% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $32.5

    Price Target Difference

    n/a
    		 48.5%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 6
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 $19.18

    Lynch Upside

    n/a
    		 -12.34%

    Graham Number

    n/a
    		 13.83

    Graham Upside

    n/a
    		 -36.79%

    Scores

    Altman Z-Score

    n/a
    		 18.35

    Piotroski F-Score

    n/a
    		 7

    Add to Watchlist